HCPCS Level IIdrugActive
J1597
Inj glycopyrrolate, glyrx-pf
BETOS: O1E
Effective: 2024-07-01
Description
Injection, glycopyrrolate (glyrx-pf), 0.1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Glyrx-Pf
Manufacturer
Exela Pharma Sciences, LLC
HCPCS Dosage
0.1 MG
Billing Units
4.0000
3
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.